Literature DB >> 3486373

The role of phospholipases from inflammatory macrophages in demyelination.

J Trotter, M E Smith.   

Abstract

Activated macrophages harvested from rat peritoneum were shown to contain phospholipase A1, A2 and lysophospholipase activities which were defined on a series of radiolabelled phospholipid substrates. During in vitro culture of these elicited macrophage populations, phospholipase enzymes were secreted into the culture medium. Radiolabelled myelin, prepared from young rats after intracerebral injection of 14C acetate, was used as a substrate to analyze the susceptibility of central nervous system (CNS) myelin to attack by cell-associated and secreted macrophage enzymes. Homogenates of peritoneal macrophages degraded the myelin lipids at acid pH; phosphatidyl choline (PC) and ethanolamine phosphatide (EP) were both degraded with liberation of free fatty acid and small amounts of lysolipids. The ethanolamine lipids were most vulnerable; up to 20% of this fraction was degraded in six hours. Selected batches of macrophage culture supernatant similarly degraded the myelin EP at acid pH. These results suggest that phospholipase enzymes, released from activated macrophages in close proximity to the myelin sheath, may participate in primary demyelination in inflammatory CNS lesions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486373     DOI: 10.1007/BF00965009

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  27 in total

1.  Molecular mechanisms in tumor-cell killing by activated macrophages.

Authors:  D O Adams; C F Nathan
Journal:  Immunol Today       Date:  1983-06

2.  The activity of pure phospholipase A2 from Crotalus atrox venom on myelin and on pure phospholipids.

Authors:  E Coles; D L Mcilwain; M M Rapport
Journal:  Biochim Biophys Acta       Date:  1974-01-23

3.  [On the activity of phospholipase A2 compared with 1-alk-1'-enyl-2-acyl- and 1-alkyl-2-acyl-glycerophosphatides in multiple sclerosis (author's transl)].

Authors:  H Woelk; K Peiler-Ichikawa
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

4.  Resistance to disruption of multilamellar fragments of central nervous system myelin.

Authors:  J Sedzik; A D Toews; A E Blaurock; P Morell
Journal:  J Neurochem       Date:  1984-11       Impact factor: 5.372

5.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

6.  Acyltransferase-catalyzed cleavage of arachidonic acid from phospholipids and transfer to lysophosphatides in lymphocytes and macrophages.

Authors:  J Trotter; I Flesch; B Schmidt; E Ferber
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

7.  Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination.

Authors:  W Cammer; B R Bloom; W T Norton; S Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

8.  Plasmalogenase is elevated in early demyelinating lesions.

Authors:  L A Horrocks; S Spanner; R Mozzi; S C Fu; R A D'Amato; S Krakowka
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

9.  Multiple sclerosis: distribution of T cell subsets within active chronic lesions.

Authors:  U Traugott; E L Reinherz; C S Raine
Journal:  Science       Date:  1983-01-21       Impact factor: 47.728

10.  Immunocytochemical localization of basic protein in major dense line regions of central and peripheral myelin.

Authors:  F X Omlin; H D Webster; C G Palkovits; S R Cohen
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  7 in total

1.  Arachidonic and docosahexanoic acid content of bovine brain myelin: implications for the pathogenesis of multiple sclerosis.

Authors:  K A Ansari; D W Shoeman
Journal:  Neurochem Res       Date:  1990-01       Impact factor: 3.996

2.  Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.

Authors:  K D Pavelko; B G van Engelen; M Rodriguez
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

3.  NPGB-induced inhibition of superoxide anion production by normal Lewis rat macrophages.

Authors:  A Arduini; G Mancinelli; M Belfiglio; J DeJulia; V Damonti; S Storto; G Federici
Journal:  Neurochem Res       Date:  1989-01       Impact factor: 3.996

4.  Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies.

Authors:  N J Scolding; D A Compston
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

5.  Immunological mechanisms of demyelination.

Authors:  R A Hughes
Journal:  J R Soc Med       Date:  1992-01       Impact factor: 18.000

6.  Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.

Authors:  Kentaro Kato; Daijiro Konno; Martin Berry; Fumio Matsuzaki; Ann Logan; Alicia Hidalgo
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

Review 7.  Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells.

Authors:  Hwan Tae Park; Young Hee Kim; Kyung Eun Lee; Jong Kuk Kim
Journal:  Cell Mol Life Sci       Date:  2019-12-28       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.